About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MORbidity PRevalence Estimate In StrokE | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT03605381

MORbidity PRevalence Estimate In StrokE

Information regarding the likely progress of post-stroke symptoms is vitally important to stroke survivors to allow them to plan for the future and to adjust to life after stroke. Moreover, the preval...

Lead sponsor: Aneurin Bevan University Health Board•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Alexander Smith, BSc-MA-MRCOT

CONTACT

+44(0)1633 238729 [email protected]

Sponsors

Lead Sponsor

Aneurin Bevan University Health Board

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinically confirmed diagnosis of stroke either;
•* Cerebral Infarct (ICD I63) \[1\]
•* Intracerebral Haemorrhage (ICD I61) \[1\]
•* Stroke, not specified as haemorrhage or infarction (ICD I64) \[1\]
•18 years of age or older (≥ 18 years old)
•Received a clinically confirmed diagnosis of stroke within the previous 14 days (Stroke diagnosis ≤ 14 days)

Exclusion Criteria

•Clinically confirmed diagnosis of any of the following
•* Transient Ischaemic Attack (ICD G45) \[1\]
•* Subarachnoid Haemorrhage (ICD I60) \[1\]
•* Any condition defined under ICD G93 e.g. Anoxic brain damage \[1\]
•* Patients receiving or eligible for Palliative Care.

Related studies

Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke

NCT05600374 · Ischemic Stroke, Acute

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

NCT07575867 · Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation, and more

Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke

NCT07084025 · Stroke, Cerebrovascular Disorders

Neurofeedback Intervention for Reading Deficits in Subacute Stroke

NCT04875936 · Stroke, Dyslexia, Acquired

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

NCT06292117 · Ischemic Stroke, CYP2C19 Polymorphism

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 5, 2019Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment500

Start dateSep 2018

Last updatedJul 5, 2019

Condition

Stroke CVA (Cerebrovascular Accident)CVA; Sequelae Stroke, Ischemic Stroke Hemorrhagic+12 more

Locations shown

Ysbyty Ystrad Fawr

Ystrad Mynach, Caerphilly

Royal Gwent Hospital

Newport, Gwent

Prince Charles Hospital

Merthyr Tydfil

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 5, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions